Millenia Hope shares trading status

    WILMINGTON, DE, and MONTREAL, QC, April 18 /CNW Telbec/ - Millenia Hope
Inc. (OTC:PS: MLHP, Frankfurt-MLF) wishes to announce that, as of April 18,
2007, the company's securities will be available for quotation on the OTC pink
sheets. The company will be listed as a fully reporting SEC company that is
current in reporting requirements with the SEC. Quotes will be available on
the Pink Sheets under the symbol MLHP by going to the website
( , where the investor will be able to
obtain the bid and ask for MLHP. You may also call your registered broker to
obtain a quote or trade the stock, as you have done until now.
    Millenia Hope is current with its filings with the SEC, available on the
SEC's EDGAR site. Management wishes to confirm that it is business as usual
and will continue with the implementation of its business plan, which is
proceeding on track. Millenia and its affiliated company, Millenia Hope
Biopharma, are very pleased with future prospects, are enthusiastic about the
near future, and are looking forward to a very exciting and productive year in
2007. Our investors continue to show great interest with the prospective
financing plans, currently in place.
    We are vigorously striving to reach our goals and we are reviewing all
our options to create the greatest possible shareholder value. We will keep
all our shareholders and the market updated on a regular basis, as new
developments occur.


    Millenia Hope develops innovative treatments and products that enhance
the quality of life, has put in place programs to fight major infectious
diseases, and promote healthier lives.


    Pink Sheets,, is a provider of pricing and financial
information for the OTC securities market and operates the Electronic
Quotation service for OTC Equities for market makers and other broker dealers
registered under the Securities Exchange Act of 1934. Pink Sheets has created
a new issuer classification system in order to provide more transparency to
the investors about the ability and willingness of individual issuers to
provide adequate public disclosure in a credible and timely manner.


    Certain statements made in the release may contain language describing
the plans, goals, strategies, intentions, forecasts, and expectations of
Millenia Hope/Millenia Hope Biopharma that may be referred to as
"forward-looking statements." Several important factors could cause actual
results to differ materially from those in such forward-looking statements and
Millenia Hope could encounter unanticipated obstacles and delays in developing
products, services, and markets.

For further information:

For further information: Mr. Hugo Valente, CFO, (514) 846-5757, (514)

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890